Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Hussein A Assi"'
Publikováno v:
Future Science OA, Vol 6, Iss 7 (2020)
Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs. Materials & methods: This retrospective stu
Externí odkaz:
https://doaj.org/article/4dd001446d8248e181b2ec45db483397
Autor:
Theresa Wittenberg, Pamela L. Kunz, Kathleen Hornbacker, Hussein A. Assi, Shagufta Shaheen, Robyn Silberman
Publikováno v:
Pancreas. 50:890-894
Peptide receptor radionuclide therapy (PRRT) is a treatment option for somatostatin receptor-positive, unresectable or metastatic neuroendocrine tumors (NETs). Despite high disease control rates seen with PRRT, a subset of the NET population seems to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbecf4f8f9a7b7d06fa4704d37322f32
https://doi.org/10.1097/mpa.0000000000001841
https://doi.org/10.1097/mpa.0000000000001841
Autor:
Wenzel M. Hackeng, Hussein A. Assi, Florine H.M. Westerbeke, Lodewijk A.A. Brosens, Christopher M. Heaphy
Publikováno v:
Surgical pathology clinics. 15(3)
Pancreatic neuroendocrine tumors (PanNETs) represent a clinically challenging disease because these tumors vary in clinical presentation, natural history, and prognosis. Novel prognostic biomarkers are needed to improve patient stratification and tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36726b66966fe0573a6a3e2abe26e445
https://pubmed.ncbi.nlm.nih.gov/36049835
https://pubmed.ncbi.nlm.nih.gov/36049835
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:QIM21-082
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afc0413f157cfc6234da12164dd78848
https://doi.org/10.6004/jnccn.2020.7701
https://doi.org/10.6004/jnccn.2020.7701
Autor:
Guru Sonpavde, Rafael Morales-Barrera, Mehmet Asim Bilen, Sandy T. Liu, Matthew D. Galsky, Petros Grivas, Pedro Isaacsson Velho, Neeraj Agarwal, Ignacio Duran, Leonidas Nikolaos Diamantopoulos, Christopher J. Hoimes, Evan Shreck, Abhishek Tripathi, Noah M. Hahn, Monika Joshi, Victor Sacristan Santos, Pedro C. Barata, Mark F. Lythgoe, David J. Pinato, Natalie J. Miller, Ali Raza Khaki, Alexander Sankin, Benjamin A. Gartrell, Gary H. Lyman, Hussein A. Assi, Evan Y. Yu, Alejo Rodriguez-Vida, Alexandra Drakaki, Yousef Zakharia, Ariel Ann Nelson, Jure Murgic, Lucia Alonso Buznego, Marcus Marie Moses, Michael Edward Devitt, Jayanshu Jain
Publikováno v:
J Urol
Urinary tract cancer can be pure urothelial carcinoma, pure nonurothelial carcinoma or variant urothelial carcinoma (defined here as mixed urothelial carcinoma). Little is known regarding outcomes for patients with variant urothelial carcinoma receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa14cbd9d7256c6d714b5ea21b894b7d
https://doi.org/10.1097/ju.0000000000000761
https://doi.org/10.1097/ju.0000000000000761
Publikováno v:
Future Science OA
Background: Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs. Materials & methods: This retrospective stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bc26e2987a48f9e13e02be241155df
https://pubmed.ncbi.nlm.nih.gov/32802390
https://pubmed.ncbi.nlm.nih.gov/32802390
Publikováno v:
Pancreas. 49:e95-e96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d273b23eba1c0e769a28b8c644be460d
https://doi.org/10.1097/mpa.0000000000001649
https://doi.org/10.1097/mpa.0000000000001649
Autor:
Victor Sacristan Santos, Jure Murgic, Mark F. Lythgoe, Sandy T. Liu, Benjamin A. Gartrell, Noah M. Hahn, Gary H. Lyman, Alexander Sankin, Alexandra Drakaki, Yousef Zakharia, Mehmet Asim Bilen, Pedro C. Barata, Guru Sonpavde, Christopher J. Hoimes, Ariel Ann Nelson, David J. Pinato, Monika Joshi, Rafael Morales-Barrera, Matthew D. Galsky, Abhishek Tripathi, Veena Shankaran, Hussein A. Assi, Evan Y. Yu, Michael Edward Devitt, Alejo Rodriguez-Vida, Pedro Isaacsson Velho, Ang Li, Petros Grivas, Leonidas Nikolaos Diamantopoulos, Evan Shreck, Praneeth Baratam, Ignacio Duran, John Esther, Jayanshu Jain, Lucia Alonso Buznego, Marcus Marie Moses, Ali Raza Khaki
Publikováno v:
Cancer
BACKGROUND Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance status (PS). However, the benefit of ICIs for patients with a poor PS remains unknown. It was hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13323e3355bf39d909307dc8b64aa87f
https://europepmc.org/articles/PMC7050422/
https://europepmc.org/articles/PMC7050422/
Autor:
Pamela L. Kunz, Hussein A. Assi, Sarbajit Mukherjee, Vipul Pareek, Michael Machiorlatti, Sara K. Vesely, Hassan Hatoum
Publikováno v:
The oncologist. 25(2)
BACKGROUND: Pancreatic neuroendocrine tumors (panNETs) are a rare group of tumors that make up 2%–3% of pancreatic tumors. Recommended treatment for panNETs generally consists of resection for symptomatic or large asymptomatic tumors; however, opti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8fb0b6bcd9796d4df3b3877148dc2bd
https://pubmed.ncbi.nlm.nih.gov/32043766
https://pubmed.ncbi.nlm.nih.gov/32043766
Publikováno v:
The Journal of Community and Supportive Oncology. :359-362
It is widely recognized that eosinophils are found in tumor infiltrates and that their mechanism of action is associated with particular symptoms and prognosis. However, the causes of and reasons for this process remain unclear, as does the exact mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0448813bb7eecc609fddea785a52a09b
https://doi.org/10.12788/jcso.0223
https://doi.org/10.12788/jcso.0223